Miia Kovalainen

Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices—Enhanced stability and release

Hanna Valo, Miia Kovalainen, Päivi Laaksonen et al. · Journal of Controlled Release · 2011 · 146 citations

Pharmacy, Materials Science, Pharmaceutics +16

Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations

Martti Kaasalainen, Ermei Mäkilä, Joakim Riikonen et al. · International Journal of Pharmaceutics · 2012 · 93 citations

Pharmacy, Bioengineering, Pharmaceutics +14

Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

Miia Kovalainen, Juha Mönkäre, Ermei Mäkilä et al. · Pharmaceutical Research · 2011 · 84 citations

Pharmacy, Materials Science, Pharmaceutics +16

The effects of group and single housing and automated animal monitoring on urinary corticosterone levels in male C57BL/6 mice

Remi Kamakura, Miia Kovalainen, Juhani Leppäluoto et al. · Physiological Reports · 2016 · 84 citations · Full text

Veterinary Medicine, Animal Sciences, Endocrinology +17

Nanocrystal-based per-oral itraconazole delivery: Superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption

Annika Sarnes, Miia Kovalainen, Merja R. Häkkinen et al. · Journal of Controlled Release · 2014 · 80 citations

Pharmacy, Pharmaceutics, Pharmacology +16